Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 18.22% on an annualized basis producing an average annual return of 32.21%. Currently, Krystal Biotech has a market capitalization of $5.44 billion.

Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5 years ago, it would be worth $385.53 today based on a price of $188.33 for KRYS at the time of writing.

Krystal Biotech's Performance Over Last 5 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.